FMT
PBYI icon

First Mercantile Trust’s Puma Biotechnology PBYI Stock Holding History

First Mercantile Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,890
Closed -$20K – 896
2019
Q3 		$20K Buy
1,890
+196
+12% +$2.12K ﹤0.01% 881
2019
Q2 		$22K Sell
1,694
-11
-0.6% -$253 ﹤0.01% 813
2019
Q1 		$66K Buy
1,705
+135
+9% +$4.12K 0.02% 741
2018
Q4 		$32K Buy
1,570
+120
+8% +$3.6K 0.01% 822
2018
Q3 		$66K Buy
1,450
+115
+9% +$5.54K 0.01% 761
2018
Q2 		$79K Buy
+1,335
New +$77.4K 0.02% 759
2015
Q2 		– Sell
-2,544
Closed -$601K – 1039
2015
Q1 		$601K Buy
2,544
+656
+35% +$140K 0.05% 441
2014
Q4 		$358K Buy
1,888
+171
+10% +$37.9K 0.03% 586
2014
Q3 		$409K Sell
1,717
-1,365
-44% -$280K 0.03% 580
2014
Q2 		$203K Sell
3,082
-4,345
-59% -$309K 0.02% 715
2014
Q1 		$774K Buy
7,427
+2,327
+46% +$274K 0.06% 465
2013
Q4 		$528K Buy
+5,100
New +$299K 0.04% 550

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Mercantile Trust's PBYI Position: Q4 2019 in Review

First Mercantile Trust sold out of Puma Biotechnology (PBYI) in Q4 2019, closing a stake of 1,890 shares — an estimated $20K sold.

First Mercantile Trust first reported a position in PBYI in Q4 2013 and held it in 12 quarters. The position peaked at $774K in Q1 2014. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • First Mercantile Trust reported no remaining Puma Biotechnology position as of Q4 2019 after selling out during the quarter.
  • First Mercantile Trust sold 1,890 Puma Biotechnology shares in Q4 2019, an estimated $20K.
  • First Mercantile Trust first reported a position in Puma Biotechnology in Q4 2013 and held it in 12 quarters.
  • First Mercantile Trust's Puma Biotechnology position peaked at $774K in Q1 2014.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on First Mercantile Trust's 13F filing for Q4 2019, filed 31 Jan 2020.